PDCD1 and neoplasm: It was suggested that MSI represents a classical example of adaptive resistance in which an active immune Th1/CTL microenvironment results in a compensatory induction of checkpoints, including PD-1, PD-L1, CTLA-4, IDO, and LAG-3, which protect the tumor from apoptosis [21, 41].